Deep Dives, AI, Drug Development, Drug Discovery.
drug target for chronic kidney disease. BenevolentAI’s computers predicted the target, and AstraZeneca’s experiments validated it. Another example is Japan’s Sumitomo Dainippon Pharma, which worked with Exscientia to identify DSP-1181 for obsessive compulsive disorder in less than a quarter of the